In addition, with the progress of NAFLD, microRNA-34a, apoptosis and acetylated p53 were found to be increased gradually in the hepatic tissues, while SIRT1 decreased [35]. Here, TP53 is linked to metabolic dysfunction-associated steatotic liver disease.